Lineage Cell Therapeutics Inc (LCTX) Unusual Options Activity Today

Checking LCTX unusual options activity helps you spot when traders are making outsized bets on Lineage Cell Therapeutics Inc before the broader market catches on. Lineage Cell Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor LCTX unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching LCTX unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking LCTX unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and LCTX unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy that is in Phase I/IIa multicenter clinical trial for the treatment of acute spinal cord injuries; and VAC2, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells, which is in Phase I clinical trial to treat non-small cell lung cancer.

It also offers Renevia, a facial aesthetics product. In addition, the company engages in the research and development of therapeutic products for retinal diseases, neurological diseases, and disorders and oncology. Lineage Cell Therapeutics, Inc. has a collaboration with Orbit Biomedical, Ltd. The company was formerly known as BioTime, Inc. and changed its name to Lineage Cell Therapeutics, Inc. in August 2019. Lineage Cell Therapeutics, Inc. was incorporated in 1990 and is headquartered in Carlsbad, California.

Catalysts rarely arrive without a footprint, and LCTX unusual options activity is often where that footprint shows up first. Our scanner tracks Lineage Cell Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at LCTX unusual options volume on the call side or chasing put sweeps, Lineage Cell Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.